Short-course AZT reduces HIV transmission to infants; Glaxo cuts AZT price for developing countries.
Baker
R
R
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000191:economics; D002487:Centers for Disease Control and Prevention, U.S.; D003906:Developing Countries; D016527:Drug Costs; D005260:Female; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D013785:Thailand; D014481:United States; D015215:Zidovudine / Q000008:administration & dosage* / Q000191:economics
D019380:Anti-HIV Agents; D015215:Zidovudine